Aug. 5 Financial Quick Takes: Biotech tumbles with broader markets; plus Exo, 3-V and more

Biotech stocks take a hit
U.S. biotech stocks fell in line with the broader markets Monday, with the NASDAQ Composite, NYSE Arca Biotechnology Index (BTK), SPDR S&P Biotech ETF (XBI) and BioCentury 100 each losing over 3%. The Dow Jones Industrial Average, Standard & Poor’s 500 index and NASDAQ Biotechnology Index (NBI) were down 2-3%.

Exo raises $35M series B
Exo Imaging Inc. (Redwood City, Calif.) emerged from stealth with a $35 million series B round led by Intel Capital. The company is developing a chip-based ultrasound platform for imaging and therapeutic applications and has raised $50 million since its founding in 2015. Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund and Wanxiang Healthcare Investments also participated...